Aurinia Pharmaceuticals Inc. (AUPH) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $283.06M | +20.4% |
| 2024 | $235.13M | +34.0% |
| 2023 | $175.51M | +31.0% |
| 2022 | $134.03M | +193.9% |
| 2021 | $45.60M | -9.0% |
| 2020 | $50.12M | +15660.4% |
| 2019 | $318.0K | -31.3% |
| 2018 | $463.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $283.06M | +20.4% |
| 2024 | $235.13M | +34.0% |
| 2023 | $175.51M | +31.0% |
| 2022 | $134.03M | +193.9% |
| 2021 | $45.60M | -9.0% |
| 2020 | $50.12M | +15660.4% |
| 2019 | $318.0K | -31.3% |
| 2018 | $463.0K | — |